A Modified Model Preparation for Middle Cerebral Artery Occlusion Reperfusion
May 31st, 2024
This protocol describes the process of preparing for middle cerebral artery occlusion reperfusion via the common carotid artery.
Our research scope is moderning for cerebral ischemia. We attempted to introduce silk thread from the common carotid artery and incision with five silk thread from the common carotid artery and the external carotid artery. The method is considered to have insufficient but the method is considered to affect the blood supply to the muscle.
The operation is complex and to beginners. Our protocol address the above, ensues and provides an alternative approach. Our protocol makes it easier for more practitioners to master cerebral ischemic moderning and quickly discover potential neuroprotective drugs.
After anesthetizing the rat and disinfecting the surgical area, make a two-centimeter incision along the midline of the neck using a surgical blade. Employ retractors to laterally pull back the skin and salivary glands, exposing the sternocleidomastoid and cervical muscles. Then separate the sternocleidomastoid and cervical muscles to expose the carotid territory.
Separate the common carotid artery and identify the vascular anatomy of the common internal and external carotid artery. Then separate the common carotid artery derived, external carotid artery, and internal carotid artery. Using a 3/O silk thread, tie an easily untangled knot over the external carotid artery and common carotid artery to temporarily block blood flow.
Position a vessel clip on the common carotid artery approximately 0.5 centimeters from the first knot, and place a loose knot between the first vascular clip and the silk thread knot. Now dye the needle of a five-milliliter syringe black. Then, using the black dyed needle, create a small puncture in the common carotid artery and mark the pin holes in black.
Insert the monofilament nylon suture into the common carotid artery through the black mark. Open the vascular clip and guide the nylon wire into the internal carotid artery until it halts with slight resistance. Then tighten the second knot securely to keep the monofilament nylon suture in place inside the artery, preventing displacement from the blocking position.
Untie the knots on the external carotid artery to allow blood reperfusion. After securing the monofilament suture and withdrawing it, release the knot on the common carotid artery. Apply a vascular clip ahead of the fixed monofilament suture to prevent bleeding.
Then replace the first common carotid artery knot with a vascular clip. Use tweezers to rotate the vessel incision sideways. Clamp the incision with tweezers and ligate it using a 6/O thread to repair the incision.
Remove the vascular clip, check for leaks, and confirm complete reperfusion. Laser speckle flow imaging revealed that before occluding the middle cerebral artery, or MCA, there was abundant blood flow in the MCA area. Upon occlusion of the MCA, the blood flow value on the ischemic side of the brain rapidly decreased.
Blood flow on the ischemic side was rechecked before removing the suture, confirming MCA occlusion with only a slight change in blood flow. Upon withdrawing the suture, blood flow perfusion swiftly recovered.
Overview
This protocol describes the process of preparing for middle cerebral artery occlusion reperfusion via the common carotid artery. The method aims to simplify the complex procedure for practitioners, facilitating the study of cerebral ischemia.
Key Study Components
Area of Science
- Neuroscience
- Cerebral Ischemia
- Neuroprotection
Background
- The study focuses on cerebral ischemia and its effects.
- Silk thread is introduced from the common carotid artery.
- The operation is complex, particularly for beginners.
- The protocol aims to provide an alternative approach to enhance accessibility.
Purpose of Study
- To simplify the procedure for middle cerebral artery occlusion reperfusion.
- To enable more practitioners to master the technique.
- To facilitate the discovery of potential neuroprotective drugs.
Methods Used
- Preparation for middle cerebral artery occlusion.
- Use of silk thread for arterial occlusion.
- Incision techniques involving the common and external carotid arteries.
- Addressing the complexities of the operation for beginners.
Main Results
- The protocol provides a clearer method for practitioners.
- It addresses the insufficiencies of previous methods.
- Facilitates the study of neuroprotective drugs.
- Enhances understanding of blood supply effects on muscle.
Conclusions
- The protocol simplifies a complex surgical procedure.
- It improves accessibility for researchers in the field.
- Encourages further exploration of neuroprotective strategies.
Frequently Asked Questions
Executive Industry Relevance
The modified middle cerebral artery occlusion reperfusion (MCAO/R) model addresses critical reproducibility and translational challenges in preclinical stroke research. By preserving vascular integrity and enabling reliable reperfusion, this protocol enhances predictive confidence for neuroprotective drug discovery and mechanistic de-risking at the early discovery stage. Its operational simplicity supports broader adoption and standardization across enterprise R&D portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables robust interrogation of neuroprotective hypotheses in a controlled ischemic environment.
- Supports functional target validation by inducing reproducible ischemic nerve damage.
- Facilitates mechanistic de-risking through quantifiable neurological and histological endpoints.
Screening & Assay Development
- Provides a validated in vivo system for evaluating candidate neuroprotective compounds.
- Standardizes neurological scoring and tissue staining for quantitative, reproducible outputs.
- Ensures assay readiness for high-confidence compound screening and comparative studies.
Translational & Preclinical Research
- Aligns with disease-relevant pathophysiology for translational biomarker assessment.
- Enables continuity from early discovery through preclinical efficacy validation.
- Supports risk-adjusted advancement decisions based on reproducible ischemic outcomes.
Pipeline & Workflow Integration
This modified MCAO/R model fits within the early discovery to preclinical validation continuum for neuroprotective drug development.
- Discovery Biology: Facilitates hypothesis testing and pathway clarification in cerebral ischemia models.
- Screening: Delivers reproducible, quantitative neurological and histological readouts for compound evaluation.
- Analytics: Provides standardized measurements such as laser speckle flow imaging and TTC staining for cross-condition comparison.
- Translational Research: Bridges discovery and preclinical phases with disease-relevant endpoints.
- Enterprise Reuse: Offers a scalable, standardized protocol adaptable across research teams and studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in neuroprotection studies.
- Operational Value: Simplifies complex procedures, improving reproducibility and scalability for multi-site R&D.
- Strategic Value: Enables more informed go/no-go decisions and capital-efficient portfolio management.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of neuroprotective candidates.
Implementation Considerations
- Requires expertise in microsurgical techniques and rodent vascular anatomy.
- Needs access to laser speckle flow imaging and standardized neurological scoring tools.
- Demands cross-team adherence to protocol for reproducibility and data comparability.
- Adaptable to various rodent models but may require optimization for different strains or ages.
- Potential limitations include surgical learning curve and model-specific variability in ischemic outcomes.
